Skip to main content
. 2011 Apr 18;4:43–48. doi: 10.2147/CEG.S18051

Figure 1.

Figure 1

Mean percent improvement in global IBS symptoms at the end of rifaximin treatment. The mean percent improvement in global IBS symptoms was similar in patients with IBS who received rifaximin 1200 mg/day for 10 days (52%) and in patients with IBS who received subsequent high-dose rifaximin (2400 mg/day) for 10 days (53%).

Note: aIncludes patients who received additional high-dose rifaximin therapy.

Abbreviation: IBS, irritable bowel syndrome.